Vaccination to prevent atherosclerotic cardiovascular diseases

被引：11
作者：
Laufs, Ulrich [1 ]
Ference, Brian A. [2 ,3 ]
机构：
[1] Univ Klinikum Leipzig, Klin & Poliklin Kardiol, Liebigstr 20, D-04103 Leipzig, Germany
[2] Univ Bristol, Inst Adv Studies, Bristol, Avon, England
[3] Wayne State Univ, Div Cardiovasc Med, Cardiovasc Genom Res Ctr, Sch Med, Detroit, MI USA
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷 / 32期
关键词：
SUBTILISIN/KEXIN TYPE 9; CHOLESTEROL; RISK; PCSK9;
D O I：
10.1093/eurheartj/ehx302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2508 / 2510
页数：3
相关论文
共 15 条
  • [1] 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
    Catapano, Alberico L.
    Graham, Ian
    De Backer, Guy
    Wiklund, Olov
    Chapman, M. John
    Drexel, Heinz
    Hoes, Arno W.
    Jennings, Catriona S.
    Landmesser, Ulf
    Pedersen, Terje R.
    Reiner, Zeljko
    Riccardi, Gabriele
    Taskinen, Marja-Riita
    Tokgozoglu, Lale
    Verschuren, W. M. Monique
    Vlachopoulos, Charalambos
    Wood, David A.
    Luis Zamorano, Jose
    [J]. ATHEROSCLEROSIS, 2016, 253 : 281 - 344
  • [2] Active immunotherapy for chronic diseases
    Bachmann, Martin F.
    Whitehead, Piers
    [J]. VACCINE, 2013, 31 (14) : 1777 - 1784
  • [3] A cholesterol-lowering VLP vaccine that targets PCSK9
    Crossey, Erin
    Amar, Marcelo J. A.
    Sampson, Maureen
    Peabody, Julianne
    Schiller, John T.
    Chackerian, Bryce
    Remaley, Alan T.
    [J]. VACCINE, 2015, 33 (43) : 5747 - 5755
  • [4] Immunization against proprotein convertase subtilisin-like/kexin type 9 lowers plasma LDL-cholesterol levels in mice
    Fattori, Elena
    Cappelletti, Manuela
    Lo Surdo, Paola
    Calzetta, Alessandra
    Bendtsen, Claus
    Ni, Yan G.
    Pandit, Shilpa
    Sitlani, Ayesha
    Mesiti, Giuseppe
    Carfi, Andrea
    Monaci, Paolo
    [J]. JOURNAL OF LIPID RESEARCH, 2012, 53 (08) : 1654 - 1661
  • [5] Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
    Ference, Brian A.
    Ginsberg, Henry N.
    Graham, Ian
    Ray, Kausik K.
    Packard, Chris J.
    Bruckert, Eric
    Hegele, Robert A.
    Krauss, Ronald M.
    Raal, Frederick J.
    Schunkert, Heribert
    Watts, Gerald F.
    Boren, Jan
    Fazio, Sergio
    Horton, Jay D.
    Masana, Luis
    Nicholls, Stephen J.
    Nordestgaard, Borge G.
    van de Sluis, Bart
    Taskinen, Marja-Riitta
    Tokgozoglu, Lale
    Landmesser, Ulf
    Laufs, Ulrich
    Wiklund, Olov
    Stock, Jane K.
    Chapman, M. John
    Catapano, Alberico L.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (32) : 2459 - 2472
  • [6] Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
    Ference, Brian A.
    Robinson, Jennifer G.
    Brook, Robert D.
    Catapano, Alberico L.
    Chapman, M. John
    Neff, David R.
    Voros, Szilard
    Giugliano, Robert P.
    Smith, George Davey
    Fazio, Sergio
    Sabatine, Marc S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) : 2144 - 2153
  • [7] Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease A Mendelian Randomization Analysis
    Ference, Brian A.
    Yoo, Wonsuk
    Alesh, Issa
    Mahajan, Nitin
    Mirowska, Karolina K.
    Mewada, Abhishek
    Kahn, Joel
    Afonso, Luis
    Williams, Kim Allan, Sr.
    Flack, John M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (25) : 2631 - 2639
  • [8] Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
    Galabova, Gergana
    Brunner, Sylvia
    Winsauer, Gabriele
    Juno, Claudia
    Wanko, Bettina
    Mairhofer, Andreas
    Luehrs, Petra
    Schneeberger, Achim
    von Bonin, Arne
    Mattner, Frank
    Schmidt, Walter
    Staffler, Guenther
    [J]. PLOS ONE, 2014, 9 (12):
  • [9] Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease
    Glerup, Simon
    Schulz, Rainer
    Laufs, Ulrich
    Schlueter, Klaus-Dieter
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2017, 112 (03)
  • [10] The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
    Landlinger, Christine
    Pouwer, Marianne G.
    Juno, Claudia
    van der Hoorn, Jose W. A.
    Pieterman, Elsbet J.
    Jukema, J. Wouter
    Staffler, Guenther
    Princen, Hans M. G.
    Galabova, Gergana
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (32) : 2499 - U143
12